- Home
- HCAT
HCAT
Health Catalyst Inc
as 03-28-2025 4:00pm EST
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
| Founded: | 2008 | Country: | United States |
| Employees: | N/A | City: | SOUTH JORDAN |
| Market Cap: | 318.2M | IPO Year: | 2019 |
| Target Price: | $9.27 | AVG Volume (30 days): | 837.2K |
| Analyst Decision: | Buy | Number of Analysts: | 11 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.15 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.76 - $9.24 | Next Earning Date: | 05-08-2025 |
| Revenue: | $306,584,000 | Revenue Growth: | 3.60% |
| Revenue Growth (this year): | 11.33% | Revenue Growth (next year): | 9.68% |
Stock Insider Trading Activity of Health Catalyst Inc (HCAT)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Landry Benjamin | HCAT | General Counsel | Mar 6 '25 | Sell | $4.55 | 13,827 | $62,860.31 | 160,437 | |
| LeSueur Daniel | HCAT | Chief Operating Officer | Mar 5 '25 | Sell | $4.52 | 16,902 | $76,331.12 | 216,250 | |
| Llewelyn Linda | HCAT | Chief People Officer | Feb 18 '25 | Sell | $5.43 | 6,441 | $34,952.73 | 85,819 | |
| LeSueur Daniel | HCAT | Chief Operating Officer | Feb 5 '25 | Sell | $5.76 | 5,209 | $30,007.49 | 216,250 | |
| Llewelyn Linda | HCAT | Chief People Officer | Jan 15 '25 | Sell | $5.80 | 6,442 | $37,348.14 | 85,819 | |
| LeSueur Daniel | HCAT | Chief Operating Officer | Jan 6 '25 | Sell | $7.51 | 5,209 | $39,134.18 | 216,250 | |
| Landry Benjamin | HCAT | General Counsel | Jan 6 '25 | Sell | $7.52 | 2,500 | $18,795.50 | 160,437 | |
| Gallagher Duncan | HCAT | Director | Dec 30 '24 | Sell | $6.93 | 4,500 | $31,184.10 | 69,938 |
Latest Health Catalyst Inc News
HCAT Breaking Stock News: Dive into HCAT Ticker-Specific Updates for Smart Investing
Zacks
5 days ago
Is the Options Market Predicting a Spike in Health Catalyst (HCAT) Stock?
StockStory
16 days ago
3 Small-Cap Stocks in Hot Water
StockStory
18 days ago
Q4 Earnings Outperformers: Samsara (NYSE:IOT) And The Rest Of The Data Analytics Stocks
MT Newswires
19 days ago
Health Catalyst Repurchases $5 Million in Common Stock
PR Newswire
19 days ago
Health Catalyst Announces ~$5 Million Stock Repurchase
StockStory
23 days ago
1 Software Stock with Exciting Potential and 2 to Ignore
Simply Wall St.
a month ago
Health Catalyst Full Year 2024 Earnings: EPS Misses Expectations
Hospital Management
a month ago
Signature Healthcare selects Ignite ecosystem to improve analytic capabilities
Compare HCAT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "HCAT Health Catalyst Inc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.